• FBN1 (Fibrillin-1) Genetic Mutation Analysis
  • Lysosomal Acid Lipase, Gene Variation
  • Measles (Rubeola) Antibody, IgM
  • MGMT (O-6-methylguanine-DNA methyltransferase) Methylation Detection
  • NOTCH3 (CADASIL) Gene Mutations Analysis
  • Clostridium difficile (C. Diff), Culture
  • MSH2 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
  • HLA DQ Genotyping for Celiac Disease
  • Cyclin-D1 (BCL1) Expression, Immunohistochemistry, Tissue
  • Toxoplasma IgG
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

Turnaround Time
Access to BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.
Loading...